CREDENCE MEDSYSTEMS, INC. highlighted the shifting 3 mL autoinjector ceiling and the need for multiple delivery technologies for biologic therapies.
Published
Signal category
Research & Knowledge
Quote
“Paul highlights how the long-held 3 mL ceiling for autoinjectors is shifting, while also making an important point: biologic therapies require a broad range of injection volumes, meaning more than one delivery technology is needed.”
— CREDENCE MEDSYSTEMS, INC. team
Company
CREDENCE MEDSYSTEMS, INC.
Innovative solutions to injectable drug delivery challenges—preserving proven processes and primary containers.
- Location
- MENLO PARK, US
- Company size
- 13 employees
Credence MedSystems is an industry-recognized and award-winning innovator, addressing unmet needs in injectable drug delivery. With infrastructure and competencies to design, develop, and commercialize new products, we enable our Pharma and Biotech partners to bring new therapies to patients across the world. Guided by our Innovation Without Change® philosophy, Credence develops solutions that enhance safety, usability, and performance while integrating seamlessly into existing workflows and manufacturing processes. Our core product platforms include the Companion® prefilled syringes, Dual Chamber delivery systems, and Metered-Dosing technologies, supporting a broad range of therapeutic applications. By reducing development risk, accelerating time-to-market, and improving experiences for patients, caregivers, and healthcare providers, Credence helps our pharmaceutical and biotechnology partners bring life changing injectable therapies to market with confidence.